ESG

Industrial giant Fastenal partners with the Belfast Giants, a strategic move blending global business ambition with deep-rooted community engagement in NI.

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.

A Los Angeles jury found Johnson & Johnson liable for causing ovarian cancer, a landmark verdict that renews the company's legal battles over its talc products.

A Minnesota startup has secured major funding to advance its bioelectronic device aimed at the brain's waste clearance system for treating CNS disorders.

A simple, low-cost heart pill may hold the key to treating Alzheimer's and kidney disease. CardioPharma is now funding research to unlock its potential.

Hexnode UEM launches AI-driven automation and enhanced Zero Trust features to help German, Austrian, and Swiss firms navigate strict data laws.

A new report projects a staggering $47T cost from chronic illness by 2039. Experts say prevention and innovation could save trillions and 13.5M lives.

A new partnership aims to power a tech boom in Southwest Virginia with a massive gas-fired plant, sparking hopes for revival and questions about energy.

A new pharma-tech alliance aims to leverage quantum computing and AI to create safer opioids, but the non-binding deal faces significant hurdles.

Johnson & Johnson's TRUFILL n-BCA gains FDA approval for chronic subdural hematoma, offering a minimally invasive option to curb high rates of recurrence.

Dr. Philip Golinsky’s alumni award from Life University marks a milestone for RxWellness and the growing trend of integrated, non-surgical patient care.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

With FDA approval for a pivotal study, Pulse Biosciences' novel nanosecond ablation technology aims to make atrial fibrillation treatment safer and more precise.

Exceptional drill results reveal high-grade copper and gold, potentially reshaping the economics of NorthWest's key British Columbia mining asset.

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

Belgian metals giant Campine invests in advanced antimony recycling and moves to continuous trading, navigating a volatile market with record-breaking earnings.

A massive order for a new South American copper mine highlights the critical link between advanced mining technology and the world's green energy needs.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.